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9.4
Expression of Fas/FasL in the mouse chondrogenic ATDC5 cells
Y. Suzuki, T. Nishiyama, K. Hasuda, T. Fujishiro, S. Hayashi, 
S. Hashimoto, M. Kurosaka;
Orthopaedic Surgery, Kobe University Hospital, Kobe-shi, Japan
Purpose: *OFOEPDIPOESBMPTTJ¾DBUJPOBTLFMFUBMDBSUJMBHFUFNQMBUF
JT¾STUNBEF UIFO SFQMBDFECZCPOF *O UIJTQSPDFTTIZQFSUSPQIJD
DIPOESPDZUF VOEFSHP BQPQUPTJT BOE DBMDJ¾DBUJPO IPXFWFS UIF
mechanism of this apoptosis is not well understood. Fas/FasL 
signaling has been reported to play a part in the pathogenesis of 
cartilages in osteoarthritis or rheumatoid arthritis. The purpose of 
this study is to evaluate Fas/FasL signaling in chondrogenesis. 
Methods and Materials: Mouse chondrogenic ATDC5 cells were 
cultured and stained by Alcian blue, Alizarine red and TUNEL to 
FYBNJOFDIPOESPHFOFTJTDBMDJ¾DBUJPOBOEBQPQUPTJT"UFBDIUJNF
point, real time PCR was done to examine the expression of Fas and 
FasL. Western blotting was also done to detect caspase8 activation. 
ATDC5 cells were then treated with DcR3, a decoy receptor of FasL, 
and its effects were examined. 
Results: After a 3-week culture, Alcian blue-positive cartilage 
OPEVMFTXFSFTFFO"MJ[BSJOFSFEQPTJUJWFDBMDJ¾FEOPEVMFTXFSF¾STU
detected in 4-week-plates at the hypertrophic chondrocyte stage. 
56/&-TUBJOQPTJUJWFDFMMTXFSF¾STUEFUFDUFEJOUIFXFFLQMBUFT
at the same time as the Alizarine red-positive nodules. The results of 
real time PCR indicated that cells expressed remarkably higher level 
PG'BT-N3/"BUXFFLT/PTVDITQFDJ¾DJUZXBTPCTFSWFEJO'BT
Western blotting results showed activated caspase8 increased from 
4-week-plates. In the cells treated with DcR3, Caspase8 activation 
BOEDFMMDBMDJ¾DBUJPOXFSFCPUISFEVDFE
Conclusions: It is speculated that Fas/FasL plays a part in 
the apoptosis of hypertrophic chondrocyte in the process of 
chondrogenesis. 
9.5
Blocking VEGF with sFlt1 improves the chondrogenic regeneration 
capacity of skeletal muscle-derived stem cells
S. Kubo1, G.M. Cooper2, J.A. Phillippi3, K.A. Corsi4, A. Usas5, G. Li4,
F.H. Fu6, J. Huard4;
1Orthopaedic Surgery, Kobe University Graduate School of 
Medicine, Kobe, HYOGO, Japan, 2Department Of Surgery, University 
of Pittsburgh, Pittsburgh, United States of America, 3Stem Cell 
Reseach Center, Children‘s HOspital of Pittsburgh, Pittsburgh, 
United States of America, 4Stem Cell Research Center, Children’s 
Hospital of Pittsburgh, Pittsburgh, United States of America, 5Stem
Cell Research Center, Children’s Hospital of Pittsburgh, Pittsburgh, 
PA, United States of America, 6Department Of Orthopaedic Surgery, 
University of Pittsburgh, Pittsburgh, United States of America
Purpose: To investigate the effect of VEGF stimulation and the effect 
of blocking VEGF with its antagonist, sFlt1, on chondrogenesis using 
skeletal muscle-derived stem cells (MDSCs). 
Methods and Materials: The direct effect of VEGF on the in vitro 
chondrogenic ability of MDSCs was tested using a pellet culture 
system followed by quantitative real time PCR and histological 
analyses. Next, the effect of VEGF on chondrogenesis within the 
synovial joint was tested using genetically engineered MDSCs. In 
this model, MDSCs, transduced with a retroviral vector to express 
BMP4, were co-implanted with MDSCs transduced to express either 
VEGF or sFlt1 (a VEGF antagonist) to provide a gain- and loss-of VEGF 
function experimental design. Histological scoring was used to 
compare cartilage formation among the treatment groups. 
Results: Hyaline cartilage-like matrix production was observed in 
both VEGF treated and VEGF blocked (sFlt1 treated) pellet cultures, 
but real-time PCR revealed that sFlt1 treatment improved the 
expression of chondrogenic genes in MDSCs that were stimulated 
to undergo chondrogenic differentiation with BMP4 and TGF-b3. In 
vivo testing of articular cartilage regeneration showed that VEGF 
transduced MDSCs caused an arthritic change in the knee joint, 
and sFlt1 improved the MDSC-mediated regeneration of articular 
cartilage, compared to BMP4 alone. 
Conclusions: sFlt1 gene therapy improved BMP4- and TGF-b3-induced 
chondrogenic gene expression of MDSCs in vitro, and improved 
the persistence of regenerated articular cartilage by preventing 
vascularization and bone invasion into the articular cartilage. 
9.6
Early collagen type II expression during chondrogenesis of 
adipose tissue derived mesenchymal stem cells
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Purpose: Collagen type II is one of the most important markers of 
chondrogenesis of mesenchymal stem cells (MSCs). It hasn‘t been 
describe the temporal expression pattern of collagen type II during 
chondrogenesis of human adipose tissue derived mesencymal stem 
cells (hATMSCs). Purpose: To describe the temporal expression 
pattern of collagen type II during chondrogenesis of hATMSCs. 
Methods and Materials: Samples of Human Adipose Tissue (hAT) 
were processed with collagenase type I and mononuclear cells were 
PCUBJOFE BOE QMBUFE 8IFO I"5.4$T BDIJFWFE DPO¿VFODF 	

chondrogenic differentiation was performed. In order to evaluate 
collagen type II expression, Western blotts were performed at different 
times: 0, 1, 2, 3, 5, 7, 14 and 21 days after initiated the differentiation. 
As positive control we use human articular cartilage. 
Results: Samples of 10 patients were processed (52,6±12ml). 
5JNF UP BDIJFWF DPO¿VFODF 	
 EBZT.4$T BU UIF FOEPG
culture: 32.000±3.500cells/cm2. Collagen type II Western blots: As 
soon as third day after initiated the differentiation we detected the 
characteristic doublets banding of collagen type II, comparable to 
the positive control. 
Conclusions: Results shows that in hATMSC exposed to chondrogenic 
medium, the expression of collagen type II would be earlier than 
those from bone marrow derived MSCs. These results show that 
human Adipose Tissue is an alternative source of isolation of MSCs 
and could be useful for cellular therapy to orthopedics disorders. 
9.7
Persistent collagen type II synthesis and secretion in rapidly 
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Purpose: To determine if human articular chondrocytes(HAC) may be 
expanded in vitro to therapeutically useful numbers without losing 
collagen type II synthesis and secretion. 
Methods and Materials: HAC were expanded in vitro adherent to 
plastic or supported by their own extracellular matrix (ECM) in loose 
structures called chondrospheres. In parallel cultures the effect of 
different combinations of incubator gases was monitored. Real-
UJNF 1$3 ¿PX DZUPNFUSZ BOE FMFDUSPO NJDSPTDPQJD JNNVOPHPME
techniques were used to determine the presence of key molecules of 
DBSUJMBHJOPVT&$.1SPNPUFSNFUIZMBUJPOBOEIJTUPOFNPEJ¾DBUJPO
studies were performed to assess epigenetic mechanisms underlying 
chondrocyte dedifferentiation. 
Results: Plastic adherence quickly led to loss of collagen type II 
production. Under these conditions, low pO~2~ and increased 
pCO~2~ reduced the loss of collagen type II production, but 
reduced cell proliferation. Culturing HAC as chondrospheres allowed 
the chondrocytes to remain attached to their own ECM. Here HAC 
maintained a rounded shape, proliferated rapidly and continued to 
produce collagen type II. This was associated with high levels of Sox9 
and collagen type X mRNA expression. Collagen type I was found at 
the mRNA and intracellular protein level, but not in the ECM. Changes 
in incubator gas concentrations did not affect ECM production 
in chondrosphere cultures. Epigenetic changes associated with 
variations in collagen type II production are being examined. 
Conclusions: Supported by their own ECM in chondrospheres, HAC 
proliferate to clinically useful numbers while maintaining collagen 
type II synthesis and secretion. In vitro expansion of high numbers 
of collagen type II secreting chondrocytes may improve tissue 
engineering of joint surfaces.
